SMTL ID : 8u37.1

Crystal structure of the catalytic domain of human PKC alpha (D463N, V568I, S657E) in complex with NVP-CJL037 at 2.48-A resolution

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

monomer

Ligands

1 x V5U: (6M)-3-amino-N-{4-[(3R,4S)-4-amino-3-methoxypiperidin-1-yl]pyridin-3-yl}-6-[3-(trifluoromethoxy)pyridin-2-yl]pyrazine-2-carboxamide(Non-covalent)

V5U.1: 16 residues within 4Å: Chain A: L.27, G.28, F.32, V.35, A.48, K.50, T.83, M.99, E.100, Y.101, V.102, D.106, D.149, M.152, A.162, D.163 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:D.163 Hydrogen bonds: A:E.100, A:V.102, A:D.149 Water bridges: A:F.164

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: E.64, K.168, T.179 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.179

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Visser, M. et al., Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma. J.Med.Chem. (2024)

Release Date

2024-01-24

Peptides

Protein kinase C alpha type: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein kinase C alpha type

Related Entries With Identical Sequence